GPCR-mediated oncogenic signaling

This project focuses on the characterization of new protein targets for cancer therapy. These proteins interact with 14-3-3 proteins and function downstream of chemokine receptors involved in cancer development. The fusicoccanes FC and Cot-A, known to stabilize specific 14-3-3-target protein interactions will be evaluated to modulate GPCR-controlled pathological signalling.

Programmes

Research groups

This project bridges the research groups: